MS-DRG 951

Principal Diagnosis - Pdx

• R40.2254 Coma scale, best verbal response, oriented, 24 hours or more after hospital admission
• R40.2330 Coma scale, best motor response, abnormal flexion, unspecified time
• R40.2331 Coma scale, best motor response, abnormal flexion, in the field [EMT or ambulance]
• R40.2332 Coma scale, best motor response, abnormal flexion, at arrival to emergency department
• R40.2333 Coma scale, best motor response, abnormal flexion, at hospital admission
• R40.2334 Coma scale, best motor response, abnormal flexion, 24 hours or more after hospital admission
• R40.2350 Coma scale, best motor response, localizes pain, unspecified time
• R40.2351 Coma scale, best motor response, localizes pain, in the field [EMT or ambulance]
• R40.2352 Coma scale, best motor response, localizes pain, at arrival to emergency department
• R40.2353 Coma scale, best motor response, localizes pain, at hospital admission
• R40.2354 Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission
• R40.2360 Coma scale, best motor response, obeys commands, unspecified time
• R40.2361 Coma scale, best motor response, obeys commands, in the field [EMT or ambulance]
• R40.2362 Coma scale, best motor response, obeys commands, at arrival to emergency department
• R40.2363 Coma scale, best motor response, obeys commands, at hospital admission
• R40.2364 Coma scale, best motor response, obeys commands, 24 hours or more after hospital admission
• R40.2410 Glasgow coma scale score 13-15, unspecified time
• R40.2411 Glasgow coma scale score 13-15, in the field [EMT or ambulance]
• R40.2412 Glasgow coma scale score 13-15, at arrival to emergency department
• R40.2413 Glasgow coma scale score 13-15, at hospital admission
• R40.2414 Glasgow coma scale score 13-15, 24 hours or more after hospital admission
• R40.2420 Glasgow coma scale score 9-12, unspecified time
• R40.2421 Glasgow coma scale score 9-12, in the field [EMT or ambulance]
• R40.2422 Glasgow coma scale score 9-12, at arrival to emergency department
• R40.2423 Glasgow coma scale score 9-12, at hospital admission
• R40.2424 Glasgow coma scale score 9-12, 24 hours or more after hospital admission
• R40.2430 Glasgow coma scale score 3-8, unspecified time
• R40.2431 Glasgow coma scale score 3-8, in the field [EMT or ambulance]
• R40.2432 Glasgow coma scale score 3-8, at arrival to emergency department
• R40.2433 Glasgow coma scale score 3-8, at hospital admission
• R40.2434 Glasgow coma scale score 3-8, 24 hours or more after hospital admission
• R40.2440 Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time
• R40.2441 Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]
• R40.2442 Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department
• R40.2443 Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
• R40.2444 Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
• R41.83 Borderline intellectual functioning
• R44.8 Other symptoms and signs involving general sensations and perceptions
• R44.9 Unspecified symptoms and signs involving general sensations and perceptions
• R45.850 Homicidal ideations
• R46.0 Very low level of personal hygiene
• R46.1 Bizarre personal appearance
• R46.2 Strange and inexplicable behavior
• R46.3 Overactivity
• R46.4 Slowness and poor responsiveness
• R46.5 Suspiciousness and marked evasiveness
• R46.6 Undue concern and preoccupation with stressful events
• R46.7 Verbosity and circumstantial detail obscuring reason for contact
• R46.81 Obsessive-compulsive behavior
• R46.89 Other symptoms and signs involving appearance and behavior
• R68.13 Apparent life threatening event in infant (ALTE)
• R68.19 Other nonspecific symptoms peculiar to infancy
• R68.82 Decreased libido
• R69 Illness, unspecified
• R99 Ill-defined and unknown cause of mortality
• T36.0X6A Underdosing of penicillins, initial encounter
• T36.1X6A Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter
• T36.2X6A Underdosing of chloramphenicol group, initial encounter
• T36.3X6A Underdosing of macrolides, initial encounter
• T36.4X6A Underdosing of tetracyclines, initial encounter
• T36.5X6A Underdosing of aminoglycosides, initial encounter
• T36.6X6A Underdosing of rifampicins, initial encounter
• T36.7X6A Underdosing of antifungal antibiotics, systemically used, initial encounter
• T36.8X6A Underdosing of other systemic antibiotics, initial encounter
• T36.96XA Underdosing of unspecified systemic antibiotic, initial encounter
• T37.0X6A Underdosing of sulfonamides, initial encounter
• T37.1X6A Underdosing of antimycobacterial drugs, initial encounter
• T37.2X6A Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter
• T37.3X6A Underdosing of other antiprotozoal drugs, initial encounter
• T37.4X6A Underdosing of anthelminthics, initial encounter
• T37.5X6A Underdosing of antiviral drugs, initial encounter
• T37.8X6A Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter
• T37.96XA Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter
• T38.0X6A Underdosing of glucocorticoids and synthetic analogues, initial encounter
• T38.1X6A Underdosing of thyroid hormones and substitutes, initial encounter
• T38.2X6A Underdosing of antithyroid drugs, initial encounter
• T38.3X6A Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
• T38.4X6A Underdosing of oral contraceptives, initial encounter
• T38.5X6A Underdosing of other estrogens and progestogens, initial encounter
• T38.6X6A Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
• T38.7X6A Underdosing of androgens and anabolic congeners, initial encounter
• T38.806A Underdosing of unspecified hormones and synthetic substitutes, initial encounter
• T38.816A Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter
• T38.896A Underdosing of other hormones and synthetic substitutes, initial encounter
• T38.906A Underdosing of unspecified hormone antagonists, initial encounter
• T38.996A Underdosing of other hormone antagonists, initial encounter
• T39.016A Underdosing of aspirin, initial encounter
• T39.096A Underdosing of salicylates, initial encounter
• T39.1X6A Underdosing of 4-Aminophenol derivatives, initial encounter
• T39.2X6A Underdosing of pyrazolone derivatives, initial encounter
• T39.316A Underdosing of propionic acid derivatives, initial encounter
• T39.396A Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
• T39.4X6A Underdosing of antirheumatics, not elsewhere classified, initial encounter
• T39.8X6A Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
• T39.96XA Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
• T40.0X6A Underdosing of opium, initial encounter
• T40.2X6A Underdosing of other opioids, initial encounter
• T40.3X6A Underdosing of methadone, initial encounter
• T40.416A Underdosing of fentanyl or fentanyl analogs, initial encounter
• T40.426A Underdosing of tramadol, initial encounter